EnteroMedics

homesitemapcontact us

   search

 

   
 
EnteroMedics Mission
 
   
   
 

Overview

 
 

Our Mission

 

Management

 
 

Board of Directors

 

 

 

 

 

 

EnteroMedics® is committed to the delivery of safe, effective and sustainable therapies that address the growing global health crises associated with the increased prevalence of obesity and metabolic diseases, including diabetes and hypertension. EnteroMedics is rapidly advancing its novel technology, VBLOC® vagal blocking therapy delivered via the Maestro® Rechargeable System, to broadly benefit patients, health care providers and stakeholders around the world.

The employees of EnteroMedics are committed to:

  • Providing safe, reliable and effective products and therapies to treat obesity and metabolic disorders

  • Complying with statutory and regulatory requirements and maintaining the effectiveness of the quality management system

  • Enhancing patients’ well being by improving our products and processes through measurement of our performance with appropriate metrics